Combination Of Blood Gene Expression (AlloMap) And Donor Derived Cell Free DNA (Allosure) To Diagnose Allograft Rejection in Kidney Transplant Recipients.
Sunday, April 30, 2023
4:45 PM – 5:00 PM ET
Location: Convention Center: 204 AB
Publication Number: 2585.6
Vikas Dharnidharka, Washington University in St. Louis School of Medicine, St. Louis, MO, United States; RAJA DANDAMUDI, Washington University School of Medicine in St.Louis., St. Louis, MO, United States; Lujain Jaza, Washington University in St. Louis School of Medicine, balllwin, MO, United States; Leslie Walther, Washington University in St. Louis School of Medicine, St. Louis, MO, United States; Mansi Agarwal, Washington University in St. Louis School of Medicine, Wildwood, MO, United States; Charles Goss, Washington University in St. Louis School of Medicine, St. Louis, MO, United States; Hua (Helen) Xu, CareDx, Brisbane, CA, United States; Nimisha Sulejmani, CareDx, Brisbane, CA, United States
Presenting Author(s)
Vikas Dharnidharka, MD, MPH (he/him/his)
Alexis Hartmann Endowed Professor, Vice-Chair and Nephrology Division Chief Washington University in St. Louis School of Medicine St. Louis, Missouri, United States
Disclosure(s):
Raja Dandamudi, MD: CareDx (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Lujain Jaza, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Leslie Walther, BSN: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mansi Agarwal, Phd, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Charles Goss, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Hua (Helen) Xu, Ph.D.: CareDx (Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Nimisha Sulejmani, PharmD: CareDx (Ongoing) (Products/Services: Employment with an ineligible company)
Vikas Dharnidharka, MD, MPH: CareDx (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness); Sanofi (Ongoing) (Products/Services: Advisory Committee, Consultant)